Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Journal of Leukocyte Biology|June 1, 1991
T helper/inducer (CD4+) cells prestimulated with PPD induce monocytes to produce interleukin-1 betaN E Dunlap, A B TildenJournal of Leukocyte Biology|May 1, 1989
Interleukin-2 augmentation of interleukin-1 and prostaglandin E2 productionA B Tilden, N E DunlapSurgery|September 1, 1982
Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppressionA B Tilden, C M BalchJournal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1991
The effect of bryostatin 1 on human lymphocyte-mediated cytotoxicityA B Tilden, A S KraftSurgery|July 1, 1981
Indomethacin enhancement of immunocompetence in melanoma patientsA B Tilden, C M BalchJournal of Immunology (Baltimore, Md. : 1950)|March 1, 1983
Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibodyA B Tilden, T Abo, C M BalchJournal of Immunology (Baltimore, Md. : 1950)|February 15, 1987
Human lymphokine-activated killer (LAK) cells: identification of two types of effector cellsA B Tilden, K Itoh, C M BalchSurgery|August 1, 1985
Cellular immune defects in patients with melanoma involving interleukin-2-activated lymphocyte cytotoxicity and a serum suppressor factorC M Balch, K Itoh, A B TildenJournal of Immunology (Baltimore, Md. : 1950)|May 15, 1986
Lysis of human solid tumor cells by lymphokine-activated natural killer cellsK Itoh, A B Tilden, C M BalchCancer Research|June 1, 1986
Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomasK Itoh, A B Tilden, C M BalchPageof 5